Theriva Biologics Inc Sustainability Reports
Theriva Biologics, Inc. is a clinical-stage diversified biopharmaceutical company that develops novel therapeutics designed to treat cancer and related diseases.
Sector: Manufacturing
Country: United States
Exchange: NYSE American
LEI: 529900RVC1I52VWB3G55
FIGI: BBG001S77L07
3 reports from 2022 to 2024